1. Home
  2. RZLT vs ORMP Comparison

RZLT vs ORMP Comparison

Compare RZLT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$1.80

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$3.07

Market Cap

104.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RZLT
ORMP
Founded
2010
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
104.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RZLT
ORMP
Price
$1.80
$3.07
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.33
N/A
AVG Volume (30 Days)
9.8M
272.5K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
838.25
EPS
N/A
1.03
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.99
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$1.82
52 Week High
$11.46
$3.20

Technical Indicators

Market Signals
Indicator
RZLT
ORMP
Relative Strength Index (RSI) 22.97 74.34
Support Level $1.07 $2.66
Resistance Level $11.17 $2.84
Average True Range (ATR) 0.66 0.16
MACD -0.81 0.03
Stochastic Oscillator 7.23 80.89

Price Performance

Historical Comparison
RZLT
ORMP

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: